Trials / Recruiting
RecruitingNCT06573853
Outcomes of PFA Vs. RFA for Patients with PSVT: a Retrospective and Propensity Score Matching Study
The Safety and Efficiency of Pulsed Field Ablation and Radiofrequency Ablation in the Treatment of Paroxysmal Supraventricular Tachycardia：a Retrospective and Propensity Score Matching Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 428 (estimated)
- Sponsor
- Caijie Shen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this retrospective study is to compare the long-term follow-up outcomes of pulses field ablation (PFA) Vs. radiofrequency ablation (RFA) for the patients with paroxysmal supraventricular tachycardia (PSVT). The main question to answer is: Does the PFA was more effecient and safer that RFA for treatment of PSVT during procedure and after 1-year follow-up? Researchers will compare the acute and long-term efficiency and safety between PFA and RFA. 1. Recieved PFA or RFA 1 year ago 2. Finish the visit to the clinic at 1, 3, 6, 12 months for examinations and blood testings 3. Patients recieved PFA and PFA under propensity matched comparison according to differen variety of PSVT
Detailed description
The goal of this retrospective study is to compare the long-term follow-up outcomes of PFA Vs. RFA for the patients with PSVT. The main question to answer is: Does the PFA was more effecient and safer that RFA for treatment of PSVT during procedure and after 1-year follow-up? Researchers will compare the acute and long-term efficiency and safety between PFA and RFA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Focal Pulsed Field Ablation (PFA) | Patients in the PFA group underwent ablation procedures utilizing a force-sensing PFA catheter for the treatment of PSVT. |
| PROCEDURE | Focal Radiofrequecy Ablation (RFA) | Patients in the PFA group underwent ablation procedures utilizing force-sensing RFA catheters for the treatment of PSVT. |
Timeline
- Start date
- 2022-10-11
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
- First posted
- 2024-08-27
- Last updated
- 2024-10-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06573853. Inclusion in this directory is not an endorsement.